AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Handelsbanken disappointed with Novo Nordisk 3Q 2006 results.
(From Chemical Business NewsBase - Net Posten)
According to Handelsbanken Novo Nordisk's turnover was below expectations for all primary product areas in 3Q 2006. In particular, sales of human insulin fell by 6% relative to 3Q 2005 and contributed significantly to the negative trend. The most profitable area, NovoSeven products, which accounts for 15% of sales but 40-50% of earnings, also failed to achieve the predicted results. Handelsbanken was disappointed too with the passive …
